Bronchial hyper-responsiveness (BHR) is considered a distinctive functional characteristic of asthma and it is associated with an increased risk for developing bronchial asthma both in children and adults (1) . BHR can be detected frequently in subjects suffering from allergic rhinitis alone, thus suggesting that a common pathogenic mechanism operates in the lower airways in allergic rhinitis and asthma. The methacholine (Mch) challenge is the most commonly used and better standardized test for quantifying BHR. Also the spontaneous changes in airway patency, measured by assessing the variability of daily peak expiratory flow (PEFv), is a reliable indirect marker of BHR (2) . An increased prevalence of BHR has been demonstrated in children in a general population setting (3), as well as in adult allergic subjects with rhinitis symptoms and no evidence of asthma, related to lower respiratory tract involvement (4) . Moreover, non-asthmatic children with allergic rhinitis are most likely to have BHR (5) . Nevertheless, at the present, the clinical significance of asymptomatic BHR remains to be fully understood (6) . Many factors (e.g., atopic status, family history, sensitization, age at onset of disease, etc.) have been reported to affect at variable extent the relationships among BHR, rhinitis, and asthma, but a comprehensive evaluation of these factors together in a carefully selected population still lacks.
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An increased prevalence of bronchial hyper-responsiveness (BHR) has been demonstrated in children from a general population, and in nonasthmatic adults with allergic rhinitis. Thus, also children with allergic rhinitis are expected to be at higher risk of BHR. We evaluated the prevalence of BHR in a sample of non-asthmatic children with allergic rhinitis by means of the methacholine (Mch) bronchial challenge, and by monitorizing the airway patency using the daily peak expiratory flow variability (PEFv). Fifty-one children (ranged 6-15 years of age) with allergic rhinitis, ascertained by skin prick test to inhalant allergens, underwent a 14-day peak expiratory flow monitoring, and a Mch bronchial provocation challenge. Thirty healthy children matched for age, and sex served as control group. Thirty-one children in the rhinitis group (61%), and six (20%) in the control group were Mch+ (Mch provocative dose causing a 20% fall of forced expiratory volume in 1 s respect to baseline <2250 lg, equivalent to 11.50 lmol). In rhinitic children the PEFv did not significantly differ between Mch+ and Mch) subjects, but the total serum immunoglobulin E (IgE) were higher among Mch+. The persistent form of rhinitis was significantly associated to Mch positivity. Non-asthmatic children with allergic rhinitis displayed a high prevalence of BHR. The BHR was significantly associated with persistent rhinitis and with higher total IgE levels. Nevertheless, the spontaneous changes in airway patency, as expressed by PEFv, were within normal limits both in Mch+ and Mch) children. 
Giuseppina

Methods
Study design
The present study is a cross-sectional evaluation of bronchial hyper-responsiveness in a group of 51 children with allergic rhinitis alone and in a matched control group of 30 healthy non-allergic children. All subjects were investigated for their clinical history and underwent a careful diagnostic evaluation including: skin prick test (SPT), total serum immunoglobulin E (IgE) measurement, pulmonary function testing, and Mch bronchial challenge. All parents of the subjects signed a written informed consent. The study was approved by the inner Ethical Committee. According to the Italian law, the respect of individual privacy concerning clinical data was granted.
Subjects and diagnosis
The two groups of children were selected from consecutive outpatients attending the allergy unit of a teaching hospital for the first time. The rhinitis group consisted of patients fulfilling the following criteria:
(i) clinical diagnosis of rhinitis (7) based on the clinical history of nasal blockage, sneezing, itching, and discharge not because of common cold; (ii) positive SPT for one or more inhalatory allergens; (iii) no ongoing pharmacologic treatment for rhinitis on a regular basis or specific immunotherapy.
The subjects of the control group were seen as well at the allergy unit, but for non-respiratory symptoms (e.g., urticaria, drug intolerance): they had negative SPT and negative clinical history for rhinitis. None of the children of both groups had a history of asthma symptoms, including diurnal or nocturnal wheezing, recurrent dry cough, shortness of breath, chest tightness or exerciserelated respiratory symptoms. All of them were free from upper or lower respiratory tract infections in the 30 days preceding the study. The treatment prescription, if any, for rhinitis was postponed to the end of the study (14 days).
In the group of children with allergic rhinitis, age of disease onset, disease duration, passive smoke exposure, and family history were assessed in detail. The familial atopic risk was evaluated according to the criteria of Croner and Kjellman (8) . Allergic rhinitis was classified as persistent (symptoms at least 4 days per week and more than 4 weeks per year) or intermittent (symptoms <4 days per week or <4 weeks per year), according to the recent guidelines (9) .
Skin prick test was carried out with a standard panel of commercial extracts (Lofarma S.p.A, Milan, Italy). The panel included: Dermatophagoides pteronyssinus, grass pollen, Parietaria judaica, Phleum pratense, artemisia, olive, dog and cat dander, alternaria, and Cladosporium plus a positive (histamine 1%) and a negative (isotonic saline) control. The response was measured after 15 min as the mean value of the major diameter of the wheal and its orthogonal; a reaction of 5 mm or greater was considered positive (10) . Total serum IgE were determined in all subjects by latex nephelometry (Behring Institute, L'Aquila, Italy), log-transformed and expressed as Z-scores (11) according to age groups 6-10 and 11-16 years. All the positive SPTs were confirmed by measuring specific IgE using the FEIA-CAP System (Pharmacia, Upssala, Sweden) (12) . Specific IgE were considered positive if their concentration was 0.36 kU/l (CAP class I). A peripheral eosinophil count was also performed in allergic children.
Peak expiratory flow monitoring
All rhinitis subjects were instructed to use twice daily (after awakening and at bedtime) a portable peak expiratory flow rate meter (Mini Wright Peak Flow Meter, Clement Clarke Ltd, London, UK), performing forced expiratory maneuvers in standing position starting from vital capacity and selecting the best of three consecutive measurements. All subjects recorded on a diary card PEF measurements and any respiratory symptom occurring over the 14 consecutive day period before Mch challenge. PEFv was computed as 14-day mean of the daily differences between the highest and lowest values expressed as percent of the daily mean, according to the formula (13):
where Max, Min and X are the daily maximum, minimum, and mean values, respectively. 
Results
All the selected subjects completed the study. Rhinitis and control groups were matched for sex distribution, age, height, and baseline lung function, as summarized in Table 1 . Baseline lung function was within normal limits in both groups (17) . The median total serum IgE value in children with allergic rhinitis was significantly higher with respect to the control group (p ¼ 0.0018, MWU - (Table 2) .
In the whole sample (rhinitics and controls), significant inverse linear relationships were found between lnDRS with age (p ¼ 0.0019, R 2 ¼ 0.115 - Fig. 1 Fig. 2 ). We performed a multiple linear regression analysis between lnDRS as dependent variable and age, height, FVC, Z-score, and lnPEFv as independent variables. This analysis produced an increase in R 2 value with respect to single linear regressions: R 2 was 0.529, (p ¼ 0.0048) in the Mch+ subgroup alone. 
Discussion
The present study confirmed that the prevalence of BHR is quite high (61%) in non-asthmatic children with allergic rhinitis and about threefold higher than in a control group (20%) of matched healthy children. BHR, as measured by Mch test, resulted significantly associated with persistent rhinitis and with higher total serum IgE levels. Conversely, the spontaneous variability of airway patency, evaluated by the daily PEFv, was not different between Mch+ and Mch) children.
We selected a PD 20 cut-off value for positive BHR of 2250 lg Mch (11.50 lmol), value close to the level used in a previous study (18) . Despite the large difference in the number of Mch+ subjects between rhinitis and control groups, we found similar PD 20 values in all Mch+ subjects ( Table 1 ). The prevalence of Mch test positivity in the control group is close to that reported in other studies carried out in asymptomatic children from open populations showing that the BHR prevalence is significantly higher among normal children than among adults (19) . Indeed, Koh et al. (5) found a 37% prevalence of BHR, but this lower prevalence may be explained by both methodologic differences relevant to challenge methods and the selected cut-off value for positive BHR. Moreover, the mean total serum IgE level shown by the population sample in Koh's study was lower. As high total serum IgE level was demonstrated predictive of bronchial reactivity (20) , such difference may further account for differences in BHR prevalence. In our study, the total serum IgE level, expressed as Z-score, was significantly higher in Mch+ subjects as compared with Mch). Our results further confirm the well known correlation between atopy and BHR (21) . All subjects with positive skin tests for seasonal pollens were challenged out of the pollen season. In fact, children with perennial allergic rhinitis, the continuous exposure to an offending allergen could induce a heightened risk of BHR with respect to subjects with seasonal rhinitis (22) . In agreement, we found that a higher number of subjects with persistent symptoms was present in the Mch+ subgroup. This suggests that perennial allergen exposure can maintain a persistent inflammation and sustain BHR, thus supporting the hypothesis that inflammation acts as a link between upper and lower airways (23) .
We found a significant inverse relationship between BHR (expressed as lnDRS), and both age and height, this finding may be attributed to the effect of lung size, as expressed by age and height, on BHR (24) . Thus, the lower mean age of population sample in the present study may further explain the higher BHR prevalence we found.
In epidemiological studies, other factors were related to BHR, such as familial atopic risk, passive smoke exposure, number of SPTs, and disease duration. Our study failed in demonstrating these links. This discrepancy may be because of the homogeneity of our patients, entirely represented by children with allergic rhinitis.
Furthermore, we found that in non-asthmatic allergic children the variability of airway patency is superimposable in children with or without BHR: only four subjects (two Mch+ and two Mch)) showed a PEFv higher than 9.26%, value previously found as 95th percentile limit for asymptomatic non-asthmatic children (25) . In the present study, in rhinitis patients PEFv was significantly linearly related to DRS, even if the relationship was stronger among Mch+ subjects alone and not significant among Mch). It is noteworthy that despite this relationship, the spontaneous airway reactivity, expressed by PEFv, was not distinguishable among Mch+ and Mch) subjects. From a clinical point of view these results suggest that in non-asthmatic children the presence of BHR does not imply an abnormal behavior of airways, as found in asthmatics (2) . In rhinitic non-asthmatic children, a positive Mch test is not definitely associated with abnormal spontaneous diurnal changes in airway patency.
In conclusion, in a selected sample of children with allergic rhinitis alone we found a very high prevalence of asymptomatic BHR. This was associated with persistent rhinitis and higher total serum IgE levels. Nevertheless, the spontaneous changes in airway patency, as expressed by diurnal variability of peak expiratory flow, were within normal limits both in responder and nonresponder children.
